Clinical Trial Update: Study of FFI-1010 in Pediatric Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for FFI-1010 in pediatric kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Disease in Children

Drugs mentioned

• FFI-1010

Snippet

Sponsor: Fuji Yakuhin Co., Ltd. | Conditions: Children Under 18 Years Old With Kidney Disease | Phase 3 | Status: COMPLETED